Serum Institute wants to advance needle-free injection tech so picked 20% in IntegriMedical

Serum Institute of India (SII) has picked a 20% stake in IntegriMedical as the company envisions a needle-free solution to deliver vaccines. Financial details were not disclosed.

 

SII CEO Adar Poonawalla said, "At SII, we are constantly seeking opportunities to invest in technologies that align with our mission to make healthcare accessible and affordable for people worldwide."

 

Speaking about IntegriMedical's US-patented Needle-Free Injection System (N-FIS), Poonawalla said it represents a significant advancement in drug delivery and could revolutionise the way vaccines are administered, making the process more comfortable for patients and healthcare professionals.

 

Read more@ https://www.cnbctv18.com/india/healthcare/serum-institute-picks-20-pc-stake-in-integrimedical-to-advance-needle-free-injection-technology-n-fis-19413473.htm

Comments

Popular posts from this blog

Intramuscular Injections

Intramuscular Injections: The Future of Pain-Free Vaccinations

Subcutaneous Injections